Sign inJoin waitlistJoin the waitlist

Sukhmani Kaur Padda

Medical Oncology · Temple Faculty Practice Plan Inc

Credentials: · · · · ·

History

Research

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
Cancer Discovery · 2017 · 877 citations
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Journal of Clinical Oncology · 2019 · Last of 30 authors · 529 citations
Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer
Nature Cancer · 2020 · 313 citations

Heather Wakelee
62 papers
Joel Neal
46 papers
Kavitha Ramchandran
18 papers
Maximilian Diehn
17 papers
Millie Das
17 papers
Jonathan Riess
12 papers · 1 as a fellow
Billy Loo
11 papers
JA
Jacqueline Aredo
11 papers · 7 as a resident
JH
Jessica Hellyer
10 papers · 4 as a fellow
Joseph Shrager
10 papers
Ash Alizadeh
7 papers
Aadel Chaudhuri
6 papers · 5 as a resident

Clinical trials

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
Principal investigator · Active not recruiting · Phase 2
SWOG Cancer Research Network
2021–2027
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2036
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2023–2027
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
Sub-investigator · Recruiting · Phase 2
Kamya Sankar
2024–2027